email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

ISSN: 2637-4722

Progressing Aspects in Pediatrics and Neonatology

Mini Review(ISSN: 2637-4722)

Topic- Hemophagocytic Lymphohistiocytosis: A New Foe

Volume 1 - Issue 2

Rohit Vohra1* and Dr Minakshi2

  • Author Information Open or Close
    • 1Department of Pediatric emergency and critical care medicine, Sir Ganga Ram Hospital, India
    • 2Department of Pediatric Hematology and Oncology, Sir Ganga Ram Hospital, India

    *Corresponding author: Rohit Vohra, Department of Pediatric emergency and critical care medicine, Sir Ganga Ram Hospital, New Delhi, India

Received: February 05, 2018;   Published: February 16, 2018

DOI: 10.32474/PAPN.2018.01.000108

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Hemophagocytic lymphohistiocytosis (HLH) is an aggressive and life-threatening syndrome of excessive immune activation. It commonly affects infants from birth to 18 months of age, but the disease can be seen in children and adults of all ages. HLH can occur as a familial or sporadic disorder, and it can be triggered by a variety of events that disrupt immune homeostasis. Prompt recognition of the disease and initiation of treatment is essential for the survival of affected patients [1]..

Keywords: HLH; NK cells; Immune system

Abbrevations: HLH: Hemophagocytic lymphohistiocytosis; NK: Natural killer; CTLs: cytotoxic T- lymphocytes

Abstract| Introduction| Diagnosis| Treatment| References|